TIME-DEPENDENT INTERACTION OF A NEW H-2-RECEPTOR ANTAGONIST, IT-066, WITH THE RECEPTOR IN THE ATRIA OF GUINEA-PIG

被引:18
作者
MURAMATSU, M
HIROSEKIJIMA, H
AIHARA, H
OTOMO, S
机构
[1] Department of Pharmacology, Research Center, Taisho Pharmaceutical Co., Ltd., Ohmiya
关键词
HISTAMINE H2-RECEPTOR ANTAGONISTS; GASTRIC-ACID SECRETION; DRUG RECEPTORS; INHIBITION; YM-11170; DOGS;
D O I
10.1254/jjp.57.13
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
3-Amino-4-[4-[4-(1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1,2-dione hydrochloride (IT-066) showed a highly potent and long lasting H-2-receptor blocking action in guinea pig atria. The inhibitory effect of IT-066 on the histamine-induced positive chronotropic response increased concentration- and time-dependently. A short period of treatment with IT-066 shifted the concentration-response curve of histamine to the right in parallel, without decreasing the maximal response to histamine. With prolongation of the treatment, the concentration-response curve shifted further to the right with time-dependent suppression of the maximal response to histamine. The inhibitory effect of IT-066 was irreversible. The dissociation constant for histamine (K(A)) was not changed by prolongation of the time of incubation with IT-066. The dissociation constant for IT-066 (K(B)) was decreased with the prolongation of the treatment. Kinetic analysis of the time-dependent inhibition showed a two-step reaction: the first was reversible and the second was irreversible. Preincubation of the atria with ranitidine, however, protected the H-2-receptor from the apparently irreversible antagonism of IT-066. These results suggest that IT-066 has a time-dependent and irreversible interaction with the H-2-receptor and that the interaction may be responsible for the potent and long lasting H-2-receptor blocking action of IT-066.
引用
收藏
页码:13 / 23
页数:11
相关论文
共 27 条
  • [1] 1,2,5-THIADIAZOLE 1-OXIDE AND 1,1-DIOXIDE DERIVATIVES - A NEW CLASS OF POTENT HISTAMINE H2-RECEPTOR ANTAGONISTS
    ALGIERI, AA
    LUKE, GM
    STANDRIDGE, RT
    BROWN, M
    PARTYKA, RA
    CRENSHAW, RR
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1982, 25 (03) : 210 - 212
  • [2] BAUER RF, 1987, ANNU REP MED CHEM, V22, P191
  • [3] DEFINITION AND ANTAGONISM OF HISTAMINE H2-RECEPTORS
    BLACK, JW
    PARSONS, EM
    DURANT, CJ
    DUNCAN, WAM
    GANELLIN, CR
    [J]. NATURE, 1972, 236 (5347) : 385 - &
  • [4] BRADSHAW J, 1979, BRIT J PHARMACOL, V66, pP464
  • [5] BRIMBLECOMBE RW, 1978, GASTROENTEROLOGY, V74, P339
  • [6] BROWN T H, 1985, Drugs of the Future, V10, P51
  • [7] Buyniski J. P., 1984, HIGHLIGHTS RECEPTOR, P195
  • [8] CAVANAGH RL, 1984, FED P, V43
  • [9] Furchgott R., 1966, ADV DRUG RES, V3, P21
  • [10] Furchgott R.F., 1972, HDB EXPT PHARM CATEC, V33, P283